HHS OIG Audit – Review of Generic Drug Price Increases
Review of Generic Drug Price Increases (A-06-07-00042), October 24, 2007: “Generic drug price increases exceeded the specified statutory inflation factor applicable to brand-name drugs for 35 percent of the quarterly average manufacturer prices reviewed. If the provision for brand-name drugs were extended to generic drugs, the Medicaid program would receive additional rebates. By applying the …